HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
2.940
+0.070 (2.44%)
At close: Sep 4, 2026, 4:00 PM EDT
2.950
+0.010 (0.34%)
After-hours: Sep 4, 2026, 7:53 PM EDT
HCW Biologics Market Cap
HCW Biologics has a market cap or net worth of $5.4 million as of September 4, 2026. Its market cap has decreased by -47.73% in one year.
Market Cap
5.40M
Enterprise Value
11.22M
1-Year Change
-47.73%
Ranking
Category
Stock Price
$2.94
ChartMarket Cap Chart
Since the IPO on July 20, 2021, HCW Biologics's market cap has decreased from $285.20M to $5.40M, a decrease of -98.11%. That is a compound annual growth rate of -53.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 5.40M | 105.89% |
| Dec 31, 2025 | 2.62M | -86.80% |
| Dec 31, 2024 | 19.87M | -54.91% |
| Dec 29, 2023 | 44.07M | -35.84% |
| Dec 30, 2022 | 68.69M | -17.13% |
| Dec 31, 2021 | 82.89M | -70.94% |
| Jul 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 6.22M |
| Purple Biotech | 6.19M |
| NuCana | 6.03M |
| XTL Biopharmaceuticals | 5.88M |
| Processa Pharmaceuticals | 5.75M |
| Cardio Diagnostics Holdings | 5.50M |
| Can-Fite BioPharma | 5.36M |
| PharmaCyte Biotech | 5.22M |